REGISTERED
on 05 Mar 2024
Last Applicant/ Owned by
1209 ORANGE STREET
WILMINGTON
DE
19801
Serial Number
88295768 filed on 11th Feb 2019
Registration Number
7322945 registered on 05th Mar 2024
Correspondent Address
Bryce J. Maynard
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
LONGEVERON
Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Scientific research services involving stem cells for medical purposes Stem cells for research or scientific purposes
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Scientific research services involving stem cells for medical purposes
First Use Date in General
30th Mar 2022
First Use Date in Commerce
30th Mar 2022
Class [001]
Chemical Products
Stem cells for research or scientific purposes
First Use Date in General
30th Mar 2022
First Use Date in Commerce
30th Mar 2022
Mark Details
Serial Number
No 88295768
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 05th Mar 2024 | REGISTERED-PRINCIPAL REGISTER |
| 05th Mar 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 01st Feb 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 31st Jan 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 30th Jan 2024 | ASSIGNED TO LIE |
| 30th Jan 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 30th Jan 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 08th Sep 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 08th Jun 2023 | SU - NON-FINAL ACTION - WRITTEN |
| 08th Jun 2023 | NON-FINAL ACTION E-MAILED |